LASS5 Interacts with SDHB and Synergistically Represses p53 and p21 Activity

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|16|6|582-590

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.16, Iss.6, 2016-07, pp. : 582-590

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiproliferative Activity of Cisplatin Detected by CFSE in p53-Proficient and p53-Deficient Cells

By Ubezio Paolo   Lupi Monica   Matera Giada  

Immunological Investigations, Vol. 36, Iss. 5-6, 2007-09 ,pp. : 847-859

Informa Healthcare

Access to resources Recommend Favorite

p53 and p21WAF1 Expression in Lymphocytic Thyroiditis and Thyroid Tumors

By Okayasu I.   Osakabe T.   Onozawa M.   Mikami T.   Fujiwara M.  

Clinical Immunology, Vol. 88, Iss. 2, 1998-08 ,pp. : 183-191

Academic Press

Access to resources Recommend Favorite

Regulation of c-Myb Activity by Tumor Suppressor p53

By Tanikawa J.   Ichikawa-Iwata E.   Kanei-Ishii C.   Ishii S.  

Blood Cells, Molecules, and Diseases, Vol. 27, Iss. 2, 2001-02 ,pp. : 479-482

Academic Press

Access to resources Recommend Favorite

Therapeutic exploitation of the p53 pathway

By Lane D.P.   Lain S.  

Trends in Molecular Medicine, Vol. 8, Iss. 4, 2002-04 ,pp. : 38-42

Elsevier

Access to resources Recommend Favorite

p53: Radiosensitivity and Antiangiogenic Effects

By Chiarugi V.   Cinelli M.   Magnelli L.  

Molecular Genetics and Metabolism, Vol. 64, Iss. 1, 1998-05 ,pp. : 7-11

Academic Press

Access to resources Recommend Favorite